80 FR 54301 - National Cancer Institute Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 80, Issue 174 (September 9, 2015)

Page Range		54301-54301
FR Document		2015-22659

Federal Register, Volume 80 Issue 174 (Wednesday, September 9, 2015)

[Federal Register Volume 80, Number 174 (Wednesday, September 9, 2015)]
[Notices]
[Page 54301]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-22659]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Omnibus R03 & R21 SEP-8.
    Date: October 27-28, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Yisong Wang, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W240, 
Rockville, MD 20850, 240-276-7157, yisong.wang@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Omnibus R03 & R21 SEP-11.
    Date: October 29, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hilton Hotel Bethesda, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Reed A. Graves, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W264, Rockville, MD 20850, 240-276-6384, 
gravesr@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Omnibus R03 & R21 SEP-3.
    Date: November 5-6, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Viatcheslav A. Soldatenkov, MD, Ph.D., 
Scientific Review Officer, Special Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892, 240-276-6378, 
soldatenkovv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Omnibus R03 & R21 SEP-1.
    Date: November 9-10, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hilton Hotel Bethesda, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Bethesda, MD 20892-8328, 240-276-6372, zouzhiq@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 3, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-22659 Filed 9-8-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 174 / Wednesday, September 9, 2015 / Notices 54301

health utility in combating the DEPARTMENT OF HEALTH AND Room 7W254, Bethesda, MD 20892, 240–
development and spread of antibiotic HUMAN SERVICES 276–6378, soldatenkovv@mail.nih.gov.
resistant bacteria. A prioritized list of 18 Name of Committee: National Cancer
bacteria of highest concern can be found National Institutes of Health Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–1.
in Table 3 of the National Action Plan Date: November 9–10, 2015.
National Cancer Institute Notice of
(https://www.whitehouse.gov/sites/ Time: 8:00 a.m. to 5:00 p.m.
Closed Meetings
default/files/docs/national_action_ Agenda: To review and evaluate grant
plan_for_combating_antibotic-resistant_ Pursuant to section 10(d) of the applications.
bacteria.pdf). Input received from the Federal Advisory Committee Act, as Place: Doubletree Hilton Hotel Bethesda,
RFI and during the public consultation amended (5 U.S.C. App.), notice is 8120 Wisconsin Avenue, Bethesda, MD
hereby given of the following meetings. 20814.
will be used by HHS to develop the
The meetings will be closed to the Contact Person: Zhiqiang Zou, MD, Ph.D.,
technical criteria and performance Scientific Review Officer, Special Review
characteristics of the diagnostic(s) for public in accordance with the
Branch, Division of Extramural Activities,
which the prize(s) will be offered. The provisions set forth in sections National Cancer Institute, NIH, 9609 Medical
design of the Challenge will take into 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Center Drive, Room 7W242, Bethesda, MD
account previous guidance obtained in as amended. The grant applications and 20892–8328, 240–276–6372, zouzhiq@
the aforementioned National Strategy the discussions could disclose mail.nih.gov.
confidential trade secrets or commercial (Catalogue of Federal Domestic Assistance
and National Action Plan to combat
property such as patentable material, Program Nos. 93.392, Cancer Construction;
antibiotic resistant bacteria.
and personal information concerning 93.393, Cancer Cause and Prevention
The agenda of the public consultation individuals associated with the grant Research; 93.394, Cancer Detection and
meeting will be devoted to presentations applications, the disclosure of which Diagnosis Research; 93.395, Cancer
and discussions on the objectives and would constitute a clearly unwarranted Treatment Research; 93.396, Cancer Biology
criteria for the antimicrobial diagnostic invasion of personal privacy. Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
challenge competition. Presentations Name of Committee: National Cancer Cancer Control, National Institutes of Health,
will focus on the need for rapid Institute Special Emphasis Panel; NCI HHS)
diagnostics to address antimicrobial Omnibus R03 & R21 SEP–8.
Date: October 27–28, 2015. Dated: September 3, 2015.
resistance; development and use of
Time: 8:00 a.m. to 6:00 p.m. Melanie J. Gray,
rapid diagnostics for drug resistant
Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory
microorganisms; pathogen/resistance
applications. Committee Policy.
markers identification versus Place: Hyatt Regency Bethesda, One [FR Doc. 2015–22659 Filed 9–8–15; 8:45 am]
phenotypic susceptibility; antibiotic Bethesda Metro Center, 7400 Wisconsin
BILLING CODE 4140–01–P
stewardship in the clinical setting; and Avenue, Bethesda, MD 20814.
regulatory perspectives on rapid Contact Person: Yisong Wang, Ph.D.,
diagnostic development. Scientific Review Officer, Special Review
Branch, Division of Extramural Activities, DEPARTMENT OF HEALTH AND
Any interested person may submit National Cancer Institute, NIH, 9609 Medical HUMAN SERVICES
written comments to be considered Center Drive, Room 7W240, Rockville, MD
during the public consultation to the 20850, 240–276–7157, yisong.wang@nih.gov. National Institutes of Health
discussion board for this Challenge Name of Committee: National Cancer
National Institute of Diabetes and
accessible on https:// Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–11. Digestive and Kidney Diseases; Notice
www.challenge.gov. This statement of Closed Meetings
should include your name, address, Date: October 29, 2015.
Time: 8:00 a.m. to 6:00 p.m.
telephone number and when applicable, Agenda: To review and evaluate grant Pursuant to section 10(d) of the
the business or professional affiliation. applications. Federal Advisory Committee Act, as
Written comments can be submitted Place: Doubletree Hilton Hotel Bethesda, amended (5 U.S.C. App.), notice is
from October 1, 2015 at 8:30 a.m. EDT 8120 Wisconsin Avenue, Bethesda, MD hereby given of the following meetings.
to October 6, 2015 at 5:00 p.m. EDT. 20814. The meetings will be closed to the
Contact Person: Reed A. Graves, Ph.D.,
This web-based discussion board also Scientific Review Officer, Research
public in accordance with the
provides an open forum for discussion Technology and Contract Review Branch, provisions set forth in sections
of this prize competition. The online Division of Extramural Activities, National 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
community is open to the public and Cancer Institute, NIH, 9609 Medical Center as amended. The grant applications and
will allow for a broad and interactive Drive, Room 7W264, Rockville, MD 20850, the discussions could disclose
discussion of the topics covered by this 240–276–6384, gravesr@mail.nih.gov. confidential trade secrets or commercial
public consultation. This platform will Name of Committee: National Cancer property such as patentable material,
Institute Special Emphasis Panel; NCI and personal information concerning
allow users to submit ideas about a Omnibus R03 & R21 SEP–3.
desired diagnostic test and to comment individuals associated with the grant
Date: November 5–6, 2015. applications, the disclosure of which
on the ideas that have been submitted Time: 8:00 a.m. to 6:00 p.m. would constitute a clearly unwarranted
by others. Agenda: To review and evaluate grant
applications.
invasion of personal privacy.
Dated: September 1, 2015.
Lhorne on DSK5TPTVN1PROD with NOTICES

Place: Bethesda North Marriott Hotel & Name of Committee: National Institute of
Lawrence A. Tabak, Conference Center, 5701 Marinelli Road, Diabetes and Digestive and Kidney Diseases
Deputy Director, National Institutes of Health. Bethesda, MD 20852. Special Emphasis Panel; Time-Sensitive
[FR Doc. 2015–22690 Filed 9–8–15; 8:45 am] Contact Person: Viatcheslav A. Obesity.
Soldatenkov, MD, Ph.D., Scientific Review Date: September 30, 2015.
BILLING CODE 4140–01–P
Officer, Special Review Branch, Division of Time: 1 p.m. to 2:30 p.m.
Extramural Activities, National Cancer Agenda: To review and evaluate grant
Institute, NIH, 9609 Medical Center Drive, applications.

VerDate Sep<11>2014 14:19 Sep 08, 2015 Jkt 235001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\09SEN1.SGM 09SEN1

Document Created: 2015-12-15 09:53:10
Document Modified: 2015-12-15 09:53:10

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 27-28, 2015.
FR Citation		80 FR 54301